Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis

Programmed cell death protein-1 (PD-1) inhibitors have shown promising results for treating advanced hepatocellular carcinoma (HCC). However, the clinical utility of such inhibitors in HCC patients with vascular tumor thrombosis remains unclear. This study investigated PD-1 inhibitor efficacy in adv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Immunother
Main Authors: Tsai, Hong-Ming, Han, Meng-Zhi, Lin, Yih-Jyh, Chang, Ting-Tsung, Chen, Chiung-Yu, Cheng, Pin-Nan, Chuang, Chiao-Hsiung, Wu, I-Chin, Chen, Po-Jun, Kang, Jui-Wen, Chiu, Yen-Cheng, Chiu, Hung-Chih, Chien, Shih-Chieh, Kuo, Hsin-Yu
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8195886/
https://ncbi.nlm.nih.gov/pubmed/33409737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02845-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados